Beijing Strong Biotechnologies, Inc.
300406.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.3B
Close$
$19.52
52.6% upside
Current Fair Value
52.6% upsideUndervalued by 52.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.30 Billion |
|---|---|
| Enterprise Value | $7.91 Billion |
| Annual dividend | $1.20 |
| Dividend yield | 8.43% |
| Earnings per Share | $0.32 |
| Beta | 0.27 |
| Outstanding Shares | 582,764,544 |
Return
| Return on Equity | 6.99% |
|---|---|
| Return on Assets | 5.14% |
| Return on Invested Capital | 11.67% |
Valuation & Multiples
| P/E Ratio | 28.98 |
|---|---|
| PEG | 109.68 |
| Price to Sales | 6.4 |
| Price to Book Ratio | 2.13 |
| Enterprise Value to Revenue | 5.75 |
| Enterprise Value to EBIT | 14.43 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Beijing Strong Biotechnologies, Inc.
998 employees
CEO: Hongjun Liang
Beijing Strong Biotechnologies, Inc. operates as a supplier of in-vitro diagnostic (IVD) solutions, encompassing both products and associated services, for markets within the People's Republic of China and globally. The firm's comprehens...